Title : The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia.

Pub. Date : 2020 Dec 8

PMID : 33293599






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 COX-2 induction was prevented by different antiplatelet agents, i.e., Aspirin, the TP antagonist SQ29,548, or Revacept (a dimeric soluble GPVI-Fc fusion protein). Aspirin mitochondrially encoded cytochrome c oxidase II Homo sapiens